Available Programs

Evaluating the Use of Biosimilars for Rheumatologic Conditions

Gain an expert perspective on the current regulatory approval pathways as well as the safety and efficacy data for biosimilars in this 45-minute, live Webinar.

2 upcoming events, beginning 6/27/2017More Information